3 Results for "

SUM-149 IBC cells

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "SUM-149 IBC cells" in MCE Product Catalog:

9
9 Publications Verification
Cat. No.: HY-Q45780
CAS No.: 667880-11-7
Target:  

Akt

Research Areas:  

Cancer

ZINC00640089 is a specific Lipocalin-2 (LCN2) inhibitor. ZINC00640089 inhibits cell proliferation, cell viability and reduces AKT phosphorylation levels in SUM149 cells. ZINC00640089 has good potential for research in inflammatory breast cancer (IBC) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-148364
CAS No.: 317328-17-9
Purity:  99.96%
Target:  

Lipocalin Family Akt

Research Areas:  

Cancer

ZINC00784494 is a specific Lipocalin-2 (LCN2) inhibitor. ZINC00784494 inhibits cell proliferation, cell viability and reduces AKT phosphorylation levels in SUM149 cells. ZINC00784494 has good potential for research in inflammatory breast cancer (IBC) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-159059
Purity:  41.20%
Ganoderma Lucidum/Reishi Extract is a Ganoderma lucidum extract. Ganoderma Lucidum/Reishi Extract reduces the expression of c-Myc, BCL-2, BCL-XL, TERT, PDGFB, eIF4G, Survivin, β-catenin, and eIF4E. Ganoderma Lucidum/Reishi Extract downregulates the gene expression of MMP-9. Ganoderma Lucidum/Reishi Extract upregulates the expression of IL8. Ganoderma Lucidum/Reishi Extract is applicable to the research of inflammatory breast cancer. Ganoderma Lucidum is used in the research of various diseases, such as allergy, arthritis, hypertension, neurasthenia, inflammation, and cancer .
loading...
    loading...